Search
Menu
Cognex Corp. - Smart Sensor 3-24 GIF LB

Invitrogen Corp.

Facebook X LinkedIn Email
Invitrogen Corp. of Carlsbad, Calif., has entered into an agreement with the National Institutes of Health Chemical Genomics Center in Bethesda, Md., to identify small molecules that modulate key signaling pathways associated with disease pathophysiology. The center will use the company’s CellSensor cell lines and GeneBLAzer β-lactamase reporter gene technology to identify compounds that modulate disease signaling pathways. All of the data will be deposited in PubChem, an NIH database that links chemical structures to biological activities uncovered through screening campaigns. The research community will have access to the database.
Hamamatsu Corp. - Earth Innovations MR 2/24

Published: May 2006
BiophotonicsBusinessRapidScanSensors & Detectors

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.